Atlas Trials

TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy

Clinical trial NCT02379000 · UNKNOWN

Trial details

NCT number
NCT02379000
Sponsor
Charite University, Berlin, Germany
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Exudative Retinal DetachmentUveal Melanoma
Start date
2015-01-01
Primary completion
2017-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.